Insmed
INSM
#785
Rank
โ‚ฌ26.29 B
Marketcap
121,99ย โ‚ฌ
Share price
-0.01%
Change (1 day)
70.69%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -โ‚ฌ0.98 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚ฌ0.44 Billion. In 2024 the company made an earning of -โ‚ฌ0.73 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.98 Billion34.69%
2024 -โ‚ฌ0.73 Billion23.71%
2023 -โ‚ฌ0.59 Billion45.77%
2022 -โ‚ฌ0.41 Billion15.83%
2021 -โ‚ฌ0.35 Billion50.19%
2020 -โ‚ฌ0.24 Billion16.4%
2019 -โ‚ฌ0.2 Billion-23.9%
2018 -โ‚ฌ0.27 Billion59.35%
2017 -โ‚ฌ0.17 Billion8.52%
2016 -โ‚ฌ0.16 Billion47.25%
2015 -โ‚ฌ0.11 Billion34.53%
2014 -โ‚ฌ76.23 Million58.83%
2013 -โ‚ฌ48 Million35.14%
2012 -โ‚ฌ35.52 Million-31.92%
2011 -โ‚ฌ52.17 Million854.92%
2010 -โ‚ฌ5.47 Million-105.22%
2009 โ‚ฌ0.10 B-905.06%
2008 -โ‚ฌ13 Million-27.31%
2007 -โ‚ฌ17.88 Million-62.41%
2006 -โ‚ฌ47.55 Million98.19%
2005 -โ‚ฌ24 Million0.03%
2004 -โ‚ฌ23.99 Million159.07%
2003 -โ‚ฌ9.26 Million-69.31%
2002 -โ‚ฌ30.17 Million
2000 -โ‚ฌ27.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ14.29 B-1,585.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚ฌ8.64 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ3.90 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚ฌ0.23 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ20.33 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚ฌ3.85 M-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA